cCAM Biotherapeutics

Merck signs a $605M deal to bulk up in cancer immunotherapy
Fierce Biotech
Wed, 07/29/15 - 10:17 am
Merck
cancer immunotherapy
cCAM Biotherapeutics
CM-24
Keytruda